Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.
about
Circulating microparticles and endogenous estrogen in newly menopausal women.Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women.Ovariectomy differential influence on some hemostatic markers of mice and rats.Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins.Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause modelSex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke.Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles.Testosterone alters maternal vascular adaptations: role of the endothelial NO system.Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.Selective estrogen receptor modulators and risk for coronary heart disease.Ageing, oestrogen, platelets and thrombotic risk.Vascular actions of estrogens: functional implications.17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets.Primary prevention of cardiovascular disease with HRT.Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets.Platelet characteristics change with aging: role of estrogen receptor beta.17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets.Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
P2860
Q34476755-5567FCE7-4D56-408A-A1DD-08B04B039562Q34491825-DF7269CA-0DB0-46CA-A6F8-3925230756E9Q35086559-02A3592F-2F8C-4F77-ACCE-AC27D57B1F34Q35751419-2ABC3240-FC41-4D98-AEE2-02DDF57EEA33Q36071309-1D73573A-2500-4E91-89BD-583384BB6303Q36185871-6F3E47D7-CEF0-448A-880A-5D5764A65C0AQ36519047-9AD867D0-B959-40DA-9C28-3AA99C34CB7BQ36682542-0F3D8F0D-7035-4D5D-8AC3-BF3D24EE018CQ36758718-91009992-04B4-41AD-9A3D-482AB11A7162Q36799439-68DA43C2-B667-41FE-851E-D09AA9549DBDQ36864696-905FFF98-105E-47B1-8037-509AB4566E4DQ37088243-7EF23F94-700C-481C-9034-CA574CA5757AQ37170186-E863F29C-EFD6-4E85-9E64-DABDBF93AEC1Q37727922-3DE61285-F9C1-4814-BC16-EC4C766F189FQ37968650-90DBD660-D6E1-47A9-9FC2-27B5EC0270FCQ42480099-989DFE10-619E-46F8-BEE2-283B9D6A0EFEQ42482148-8511AAA1-25D0-4E1D-A8A8-A997B5518C1AQ51740951-FE30EFC1-0BA0-4959-9806-7970B961D302Q55060038-CA79B029-47F6-46C4-B11C-9302AF6E2337
P2860
Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Differential effects of 17beta ...... n, and secretion in platelets.
@en
Differential effects of 17beta ...... n, and secretion in platelets.
@nl
type
label
Differential effects of 17beta ...... n, and secretion in platelets.
@en
Differential effects of 17beta ...... n, and secretion in platelets.
@nl
prefLabel
Differential effects of 17beta ...... n, and secretion in platelets.
@en
Differential effects of 17beta ...... n, and secretion in platelets.
@nl
P2093
P2860
P1476
Differential effects of 17beta ...... n, and secretion in platelets.
@en
P2093
Hiroya Okano
Margarita P Bracamonte
Muthuvel Jayachandran
Peter LaBreche
Rajarshi Mukherjee
Thomas Steinkamp
Virginia M Miller
Whyte G Owen
P2860
P304
P356
10.1152/AJPHEART.01108.2004
P577
2005-01-14T00:00:00Z